Reflux Esophagitis
📧 Sign up to get email alerts when something new happens for Reflux Esophagitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: FundoRing Roux-en-Y Gastric Bypass Versus FundoRing One Anastomosis Gastric Bypass [NA]
This completed clinical trial compares FundoRing Roux-en-Y gastric bypass with FundoRing one-anastomosis gastric bypass in people with obesi…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: A Randomized, Three-Arm Study Comparing Vonaprazan 10 mg, Vonaprazan 20 mg, and Esomeprazole 40 mg for the Healing of LA Grade B or Higher Reflux Esophagitis at 8 Weeks [NA]
An ongoing randomized, three-arm trial compares vonaprazan 10 mg and 20 mg with esomeprazole 40 mg for healing LA Grade B or higher reflux e…
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal Ulcer [Phase 3]
A Phase 3 trial of Esomeplazole (D961H) in Japanese pediatric patients with reflux esophagitis, gastric ulcer, or duodenal ulcer has complet…
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: A Clinical Trial of Anaprazole for Treating Reflux Esophagitis. [Phase 3]
A Phase 3 clinical trial is recruiting to evaluate Anaprazole for treating Reflux Esophagitis.
-
CLINICAL_TRIALS trial_result · 2025-07-23Clinical Trial Update: The Phase III Clinical Trial of X842 Capsules for Reflux Esophagitis [Phase 3]
Phase III trial of X842 Capsules for Reflux Esophagitis has completed, according to the trial update.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-07-17Clinical Trial Update: Study to Evaluate the Safety and Efficacy of X842 in Patients With Reflux Esophagitis [Phase 2]
Phase 2 trial of X842 for reflux esophagitis has completed, with safety and efficacy data collected for evaluation.
-
CLINICAL_TRIALS research · 2025-04-04Clinical Trial Update: Role of ARMA in Selective Subset of Refractory GERD Patients. [NA]
This clinical trial evaluated the role of ARMA in a selective subset of patients with refractory gastroesophageal reflux disease and has com…
-
CLINICAL_TRIALS research · 2025-02-27Clinical Trial Update: A Phase III Clinical Trial for Efficacy and Safety Evaluation of JP-1366 Tablets on Reflux Esophagitis [Phase 3]
A Phase III clinical trial evaluating the efficacy and safety of JP-1366 tablets for reflux esophagitis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-12-19Clinical Trial Update: Preliminary Efficacy Analysis of "C" Single Flap Plasty Reconstruction After Laparoscopic Proximal Gastrectomy [NA]
Preliminary efficacy analysis of the 'C' single flap plasty reconstruction after laparoscopic proximal gastrectomy is reported, evaluating a…
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: Preliminary Efficacy Analysis of 'λ+α' Double-Tract Reconstruction After Laparoscopic Proximal Gastrectomy [NA]
This clinical trial update describes a preliminary efficacy analysis of the λ+α Double-Tract Reconstruction after laparoscopic proximal gast…
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: Jinghua Weikang Capsule in the Treatment of Reflux Esophagitis [Phase 4]
A Phase 4 clinical trial update regarding Jinghua Weikang Capsule for reflux esophagitis; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2023-04-14Clinical Trial Update: The Efficacy and Safety of DWP14012 in Chinese Patients With Reflux Esophagitis [Phase 3]
Phase 3 trial assessing the efficacy and safety of DWP14012 in Chinese patients with reflux esophagitis has completed.
-
CLINICAL_TRIALS withdrawal · 2023-02-01Clinical Trial Update: Trimebutine Maleate Combined With Rabeprazole in Patients With Grade A or B Reflux Esophagitis Whose Symptoms Refractory to Rabeprazole [Phase 4]
Phase 4 trial of trimebutine maleate combined with rabeprazole for refractory reflux esophagitis was withdrawn.
-
CLINICAL_TRIALS trial_result · 2022-11-03Clinical Trial Update: A Study of Anaprazole Sodium Enteric-coated Tablets in the Treatment of Reflux Esophagitis [Phase 2]
Phase 2 clinical trial update for Anaprazole Sodium Enteric-coated Tablets in reflux esophagitis (reflux esophagitis/gastroesophageal reflux…
-
CLINICAL_TRIALS research · 2022-09-22Clinical Trial Update: Trial to Assess the Effects of an Antimicrobial Mouthwash on the Esophageal Microbiome [NA]
Completed clinical trial evaluating the effects of an antimicrobial mouthwash on the esophageal microbiome; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2019-12-12Clinical Trial Update: Drug Use Surveillance of Vonoprazan for "Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis"
A completed clinical trial update for vonoprazan assessing gastric ulcer, duodenal ulcer, and reflux esophagitis with results posted in 2019…
-
CLINICAL_TRIALS trial_result · 2019-10-23Clinical Trial Update: Special Drug Use Surveillance of Vonoprazan for "Maintenance Therapy of Reflux Esophagitis: Long-term Use"
This is a post-marketing surveillance study evaluating long-term vonoprazan for maintenance therapy of reflux esophagitis, with results post…
-
CLINICAL_TRIALS trial_result · 2019-03-29Clinical Trial Update: Vonoprazan Study of Investigating the Effect on Sleep Disturbance Associated With Reflux Esophagitis- Exploratory Evaluation [Phase 4]
Phase 4 exploratory trial evaluating the effect of vonoprazan on sleep disturbance associated with reflux esophagitis has completed with pos…
-
CLINICAL_TRIALS trial_result · 2017-06-21Clinical Trial Update: Nexium Capsules S-CEI for Justification of Esomeprazole in Acid Related Disease for Reflux Symptom Healing Based on Patient Clinical Outcomes
A completed clinical trial evaluating Nexium capsules S-CEI (esomeprazole) for acid-related disease in reflux esophagitis, reporting patient…
-
CLINICAL_TRIALS trial_result · 2017-01-19Clinical Trial Update: A Phase I/III Study of D961H 10 mg and 20 mg in Japanese Paediatric Patients With Gastrointestinal Acid Related Diseases [Phase 3]
Phase III results for D961H at 10 mg and 20 mg in Japanese pediatric patients with gastrointestinal acid-related diseases have been complete…
-
CLINICAL_TRIALS trial_result · 2016-05-03Clinical Trial Update: Treatment Effect Between Dexlansoprazole and Double-dose Lansoprazole in Obesity Patients With Reflux Esophagitis [Phase 4]
Phase 4 clinical trial comparing dexlansoprazole with double-dose lansoprazole in obesity-related reflux esophagitis; study status is unknow…
-
CLINICAL_TRIALS trial_result · 2015-08-14Clinical Trial Update: Compare D961H 20 mg Bid and 20 mg qd in Patients With Refractory Reflux Esophagitis (Inflammation of Lower Esophagus) [Phase 3]
A Phase 3 trial compared D961H 20 mg twice daily versus 20 mg once daily in patients with refractory reflux esophagitis; the study completed…
-
CLINICAL_TRIALS trial_result · 2014-10-31Clinical Trial Update: Nexium Capsules RE Maintenance Specific Clinical Experience Investigation
A completed clinical trial evaluated maintenance therapy with Nexium capsules for repeatedly recurring or relapsing reflux esophagitis.
-
CLINICAL_TRIALS trial_result · 2014-07-10Clinical Trial Update: Study to Investigate the Safety, Tolerability and Efficacy of YH4808 in Patients With Reflux Esophagitis [Phase 2]
Phase 2 study evaluating the safety, tolerability, and efficacy of YH4808 in adults with reflux esophagitis; the trial status is completed.
-
CLINICAL_TRIALS trial_result · 2013-12-31Clinical Trial Update: BE Study Between a Capsule and a Sachet Formulation of D961H by Pharmacodynamics in Japanese Healthy Male Subjects [Phase 1]
Phase 1 pharmacodynamics study comparing capsule and sachet formulations of D961H in healthy Japanese male volunteers has completed.